Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
3 Hot Stocks That Have Already Doubled in 2025
11:50am, Tuesday, 18'th Feb 2025
We're just a few weeks into 2025, but some stocks are already off to the races. There are already nine U.S. exchange-listed stocks with market caps north of $1 billion that have doubled this year.
Hims & Hers Stock Is On Fire, But Is It a Bubble?
11:48am, Tuesday, 18'th Feb 2025
Shares of Hims & Hers (HIMS -0.96%) stock are up nearly 500% in the past year, but is the stock in bubble territory, or is there still growth ahead? Travis Hoium tackles that question plus the company
What Is Driving Hims & Hers Stock Higher?
11:40am, Tuesday, 18'th Feb 2025
In this video, I will talk about recent updates regarding Hims & Hers Health (HIMS -1.85%). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Hims & Hers Stock Jumps 156.9% in Three Months: What's Next?
11:20am, Tuesday, 18'th Feb 2025
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.
Hims & Hers: From Viral Ad to Volatile Stock
07:16am, Tuesday, 18'th Feb 2025
Hims & Hers Health's NYSE: HIMS share price has surged recently, climbing above $60 and creating new 52-week and all-time record highs for the company. This significant increase in Hims & Hers Health'
Hims & Hers Health Stock: A Millionaire-Maker in the Making?
04:08am, Tuesday, 18'th Feb 2025
Shares of direct-to-consumer telehealth platform Hims & Hers Health (HIMS 2.18%) have become a runaway freight train. The stock has returned nearly 20-fold returns from its 2022 lows, including a blis
Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to Note
06:45pm, Friday, 14'th Feb 2025
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $60.30, signifying a +1.88% move from its prior day's close.
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Friday, 14'th Feb 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Buy, Sell, Or Hold HIMS Stock At $60?
09:07am, Friday, 14'th Feb 2025
The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has surged an impressive 43% over the past week. A major driver of this growth was the company's widely discussed Super Bowl
Hims & Hers Health (HIMS) Surges 27.7%: Is This an Indication of Further Gains?
03:56am, Friday, 14'th Feb 2025
Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price i
3 Weight-Loss Drug Stocks to Watch
12:36pm, Thursday, 13'th Feb 2025
Weight-loss drugs have been popular over the past couple of years, and Hims & Hers Health Inc (NYSE:HIMS), Novo Nordisk A/S ( NYSE:NVO) , and Viking Therapeutics Inc (NASDAQ:VKTX) are among the
Why Hims & Hers Terrifies Big Pharma
11:51am, Wednesday, 12'th Feb 2025
Hims & Hers (HIMS 1.82%) launched a Super Bowl ad this week, and everyone from pharmaceutical companies to pharmacists tried to block it. Travis Hoium explains why that's a great sign that the company
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
08:15am, Wednesday, 12'th Feb 2025
The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are permit
Hims & Hers Health: Explosive Growth Potential Ahead
01:17am, Tuesday, 11'th Feb 2025
Hims & Hers has shown significant growth, with a 350% stock gain in 2024, driven by subscriber and revenue increases, and positive free cash flow. The company boasts a strong balance sheet with $250M
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
07:13pm, Monday, 10'th Feb 2025
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NVO -2.90%), famously the company behind Wegovy, and
